9-ING-41 in Patients With Advanced Cancers
Actuate Therapeutics Inc.
Actuate Therapeutics Inc.
Baylor College of Medicine
Dana-Farber Cancer Institute
National Institutes of Health Clinical Center (CC)
Essen Biotech
Degron Therapeutics Co.
UNC Lineberger Comprehensive Cancer Center
Washington University School of Medicine
Fudan University
Sensei Biotherapeutics, Inc.
Institut Claudius Regaud
Cancer Research UK
Chinese University of Hong Kong
Elevation Oncology
Rutgers, The State University of New Jersey
European Organisation for Research and Treatment of Cancer - EORTC
Cedars-Sinai Medical Center
Corvus Pharmaceuticals, Inc.
Shanghai Yunying Medical Technology
City of Hope Medical Center
Kineta Inc.
Eastern Cooperative Oncology Group
Quadriga Biosciences, Inc.
Ludwig Institute for Cancer Research
Roswell Park Cancer Institute
National Institutes of Health Clinical Center (CC)
University of South Florida
Celgene
National Institutes of Health Clinical Center (CC)
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
Medical University of South Carolina
Dana-Farber Cancer Institute
National Institutes of Health Clinical Center (CC)
Columbia University
AHS Cancer Control Alberta
Children's Oncology Group
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
The Cleveland Clinic
Valerio Therapeutics
Valerio Therapeutics
National Cancer Institute (NCI)
Vanderbilt University
European Organisation for Research and Treatment of Cancer - EORTC
Children's Oncology Group